Design Therapeutics, Inc. DSGN Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s operating income?
- Design Therapeutics, Inc. (DSGN) reported operating income of -$19.71M in Q1 2026.
- How has Design Therapeutics, Inc.'s operating income changed year-over-year?
- Design Therapeutics, Inc.'s operating income increased by 3.5% year-over-year, from -$20.42M to -$19.71M.
- What is the long-term trend for Design Therapeutics, Inc.'s operating income?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s operating income has grown at a 22.0% compound annual growth rate (CAGR), from -$35.83M to -$79.47M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.